Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Trends in Biotechnology|April 28, 2021
Validation Is Not Verification: Precise Terminology and Scientific Methods in Bioprocess ModelingJens Smiatek, Alexander Jung, Erich BluhmkiPharmaceutical Statistics|December 28, 2023
Comparison of nonparametric estimators of the expected number of recurrent eventsAlexandra Erdmann, Jan Beyersmann, Erich BluhmkiTrends in Biotechnology|June 11, 2020
Towards a Digital Bioprocess Replica: Computational Approaches in Biopharmaceutical Development and ManufacturingJens Smiatek, Alexander Jung, Erich BluhmkiStatistics in Medicine|September 29, 2011
How is retrospective independent review influenced by investigator-introduced informative censoring: a quantitative approachFrank Fleischer, Birgit Gaschler-Markefski, Erich BluhmkiStatistics in Medicine|July 7, 2009
A statistical model for the dependence between progression-free survival and overall survivalFrank Fleischer, Birgit Gaschler-Markefski, Erich BluhmkiStroke|May 30, 2009
Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysisMaarten G Lansberg, Erich Bluhmki, Vincent N ThijsControlled Clinical Trials|April 12, 2002
On the variability of covariate adjustment. experience with Koch's method for evaluating the absolute difference in proportions in randomized clinical trialsEmmanuel Lesaffre, Kris Bogaerts, Xin Li, et al.Biometrics|February 13, 2008
A new nonparametric approach for baseline covariate adjustment for two-group comparative studiesAlexander Schacht, Kris Bogaerts, Erich Bluhmki, et al.The International Journal of Biostatistics|May 31, 2022
Asymptotic properties of the two one-sided t-tests - new insights and the Schuirmann-constantChristian Palmes, Tobias Bluhmki, Benedikt Funke, et al.Stroke|November 3, 2007
Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trialsSean I Savitz, Robert Lew, Erich Bluhmki, et al.Pageof 6